Thermo Fisher Takes Off: Strong Profit Surge and Higher Forecasts
Reading Time: 3 minutes
Massive volume jump: Thermo Fisher Scientific significantly exceeds expectations for revenue and profit in the second quarter, triggering a huge buying wave among institutional investors. Significant forecast upgrade: Management responds to the strong operational performance and noticeably raises the forecasts for earnings (up to $25.33 per share) and revenue for the entire year 2026. Beneficiaries of the biotech boom: As the dominant supplier in the life sciences industry, the company sustainably benefits from increasing research budgets...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
